Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
By now those FUDASSIES are on everyone’s junk pile. ANAVEX is mounting the fast track with real results that amaze all. Soon ANAVEX will receive approvals so fast you’d think it was BIIB asking, but it’ll be little ole ANAVEX. Little will be history!
Been done along time ago. No requirement to tell! ANAVEX will just get approval when they ask.
Do you really speak for some regulatory agency? Which one?
Right on. The 25% short overhang is effective hold down now! It won’t be when ANAVEX gets APPROVAL for ALZHEIMER’S in record time after all the data is revealed for AD. The data has been reported in summary form and it is outstanding! The naysayers just deny deny w/o reason and against ALL odds! The revenue of $10+B per year from ALZHEIMER’S alone will drive the $AVXL stock price well above $200 instantly! Nothing more needs to be reported publically. ANAVEX will perform this way exactly as has already been reported.
Right on. The 25% short overhang is effective hold down now! It won’t be when ANAVEX gets APPROVAL for ALZHEIMER’S in record time after all the data is revealed for AD. The data has been reported in summary form and it is outstanding! The naysayers just deny deny w/o reason and against ALL odds! The revenue of $10+B per year from ALZHEIMER’S alone will drive the $AVXL stock price well above $200 instantly! Nothing more needs to be reported publically. ANAVEX will perform this way exactly as has already been reported.
You are addressing total BS from MIKE! The real facts that will quickly drive revenues for ANAVEX are:
1. Approval for A 2-73 for ALZHEIMERS in AUSTRALIA.
2. Approval for A 2-73 for ALZHEIMERS in EUROPEAN UNION, and UNITED KINGDOM ( BRITAIN & CANADA ). This can and probably will occur in MAY 2023.
3. Approval for A 2-73 for RETT SYNDROME in the UNITED STATES in JULY 2023, two months after EXCELLENCE TRIAL reports TLR! Also, award of $100M voucher from FDA.
4. Approval for A 2-73 for A 2/73 for ALZHEIMERS in the UNITED STATES in August 2023!
Net result ANAVEX ROCKETS TO $100+ in June 2023!
Not quite that young. You do know that ERN HEAVEN is now an 18 yo!
Consensus is $1249 AVXL stock price by June 2024!!
All your bullshit added really clouds what DR M actually said.
You are talking hope and speed and government work in the same sentence?The only measure of success is what the FDA SAYS. What MEDICARE SAYS comes next. What ANAVEX says might be useful. All other talk is just pure unadulterated bullshit.
So you call ANAVEX liars? They are the most honest folks on earth!
Same will happen when they give up 0%! ANAVEX doesn’t need to be a charity for BIG PHARMA.
Leech offer! We don’t need no 10% partners, just leeches!
When AVXL traded 160M shares in one day, we’re all shares shorted covered by real shares?
Forced by FDA! Is what I heard!
RTT trial in US, the first trial for RETTS, had dose of only 5mg!
No. It would help rectify the criminal trading environment that exists today! I wanna kiss the Fudster crap goodbye!
Efficacy is not as simple as you portray.
Sparks has it right.
Very little attention for that. Kind of transparent at this point. Facts will have coalesced to a solid mass which cannot be disputed!
Pesso Mist is in the air. For sure!
It’s not about MacFarlane’s excitement but the facts about ANAVEX A 2-73 to which he does give witness. All of its super responders and patients whose cognition has returned to normal.
Nice posts, ring true!
Truth is amazing. ANAVEX is amazing!
At some point this has got to be “BIG TIME CRIME”!! And some people need to serve big time!
Independent from anything other than the TLR of the ANAVEX P2b/3 AD CLINICAL TRIAL, that should be enough to drive the price of AVXL stock to over $1000. The real disconnect is that most of WS is completely divorced from reality, and only mimic others on the street. In about six months ANAVEX revenues will be printed in the WSJ.
There have been no gains for over two years in AVXL. Shorts have been on a terror raid and their war debt has accumulated. It time to come to JESUS!
The next big news AVXL will deliver is REVENUE. All newsy news will be omitted.
Why? Sounds like the perfect storm brewing for longs! I hear the word SQUEEZE!
It did on DEC 1, 2022! Look what happened, that’s why no more until revenue!
Nonsense!
It’s because we know that strong criminal forces are still manipulating the stock price of ANAVEX. Actually, we don’t expect very good results until revenues of $10B to $100B per year start rolling into the coffers of ANAVEX. That is after we show that 90% of all early ALZHEIMERS patients can return to normal to excellent cognition!
It’s actually past time for a $10+ one day move, because the ANAVEX P2b/3 AD TLR data revealed the 30 + 50 mg data vs placebo is strong results. A direct implication is that the 50mg vs placebo is phenomenal! Just remember the results from PDD TRIAL that 30mg stabilized dementia and 50mg improved cognition!-
You are confused. The decline of SAVA happened without the FART FARTSTAIN hit literature with all the FUD that you throw at ANAVEX. SAVA just sucks. SAVA pretends that OLE phase 2 is certified! Really sorry excuse of a stock!!!!
The news for ANAVEX is “Larger than world class positive results for the P2b/3 AD trial TLR readout on December 1, 2022.”
The results from ANAVEX are extremely high quality! Better than anyone else has ever reported.
Dr Missling is the “Steve Jobs of BIOSCIENCE”
SAVA is sucking for air! Just realize it.
Look even if the outcome of the filing is good then Dr M does not need to disclose until he feels the need! Just filing a NDA form how can that be a negative?
Completely disagree with Wolf! Steady is right here!
Is not a question of usual practice but of requirement. Don’t whip ANAVEX employees! There are only 25 of them. They all do their job and what is required.
“ALL ENDPOINTS MET” is ( and forever will be ) the TLR of the P2b/3 AD TRIAL reported on DECEMBER 1, 2022. Thank DR M for that result. The additional list of accomplishments is long.
When an NDA is filed cannot be material event! When an NDA is given an FDA RESPONSE of approval or not, that is material.